The dual role of CD44 as a functional P-selectin ligand and fibrin receptor in colon carcinoma cell adhesion

American Journal of Physiology - Cell Physiology

Volumn 294, Issue 4, 2008, Pages

  Alves, Christina S ^a   Burdick, Monica M ^a   Thomas, Susan N ^a   Pawar, Parag ^a   Konstantopoulos, Konstantinos ^a  

^a Johns Hopkins University   (United States)

Author keywords

Fibrinogen; LS174T colon carcinoma cells; Platelet; Shear stress; THP 1 monocytic cells

Indexed keywords

FIBRIN; FIBRINOGEN; HERMES ANTIGEN; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; RECEPTOR PROTEIN;

ARTICLE; BINDING KINETICS; CELL ADHESION; COLON CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; METASTASIS; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SHEAR FLOW; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ANTIGENS, CD44; BLOOD PLATELETS; CARCINOMA; CELL ADHESION; CELL LINE, TUMOR; COLONIC NEOPLASMS; GENE SILENCING; HUMANS; LIGANDS; P-SELECTIN; PROTEIN BINDING; RECEPTORS, PEPTIDE;

EID: 41949129307     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00463.2007     Document Type: Article

References (56)

1. Abulencia JP, Tien N, McCarty OJT, Plymire D, Mousa SA, Konstantopoulos K. Comparative antiplatelet efficacy of a novel, nonpeptide GPIIb/IIIa antagonist (XV454) and Abciximab (c7E3) in flow models of thrombosis. Arterioscler Thromb Vasc Biol 27: 149-156, 2001.
2. Ahn KC, Jun AJ, Pawar P, Jadhav S, Napier S, McCarty OJ, Konstantopoulos K. Preferential binding of platelets to monocytes over neutrophils under flow. Biochem Biophys Res Commun 329: 345-355, 2005.
3. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 61: 1303-1313, 1990.
4. Biggerstaff JP, Seth N, Amirkhosravi A, Amaya M, Fogarty S, Meyer TV, Siddiqui F, Francis JL. Soluble fibrin augments platelet/tumor cell adherence in vitro and in vivo, and enhances experimental metastasis. Clin Exp Metastasis 17: 723-730, 1999.
5. Borsig L, Wong R, Feramisco J, Nadeau DR, Varki NM, Varki A. Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci USA 98: 3352-3357, 2001.
6. Borsig L, Wong R, Hynes RO, Varki NM, Varki A. Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc Natl Acad Sci USA 99: 2193-2198, 2002.
7. Burdick MM, Konstantopoulos K. Platelet-induced enhancement of LS174T colon carcinoma and THP-1 monocytoid cell adhesion to vascular endothelium under flow. Am J Physiol Cell Physiol 287: C539-C547, 2004.
8. Burdick MM, McCaffery JM, Kim YS, Bochner BS, Konstantopoulos K. Colon carcinoma cell glycolipids, integrins, and other glycoproteins mediate adhesion to HUVECs under flow. Am J Physiol Cell Physiol 284: C977-C987, 2003.
9. Camerer E, Qazi AA, Duong DN, Cornelissen I, Advincula R, Coughlin SR. Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. Blood 104: 397-401, 2004.
10. Chan CK, Wang J, Lin L, Hao Y, Chan SO. Enzymatic removal of hyaluronan affects routing of axons in the mouse optic chiasm. Neuroreport 18: 1533-1538, 2007.
11. Crissman JD, Hatfield JS, Menter DG, Sloane B, Honn KV. Morphological study of the interaction of intravascular tumor cells with endothelial cells and subendothelial matrix. Cancer Res 48: 4065-4072, 1988.
12. Gasic GJ, Gasic TB, Stewart CC. Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci USA 61: 46-52, 1968.
13. Hanley W, McCarty O, Jadhav S, Tseng Y, Wirtz D, Konstantopoulos K. Single molecule characterization of P-selectin/ligand binding. J Biol Chem 278: 10556-10561, 2003.
14. Hanley WD, Napier SL, Burdick MM, Schnaar RL, Sackstein R, Konstantopoulos K. Variant isoforms of CD44 are P- and L-selectin ligands on colon carcinoma cells. FASEB J 20: 337-339, 2006.
15. Hanley WD, Wirtz D, Konstantopoulos K. Distinct kinetic and mechanical properties govern selectin-leukocyte interactions. J Cell Sci 117: 2503-2511, 2004.
16. Harada N, Mizoi T, Kinouchi M, Hoshi K, Ishii S, Shiiba K, Sasaki I, Matsuno S. Introduction of antisense CD44S CDNA down-regulates expression of overall CD44 isoforms and inhibits tumor growth and metastasis in highly metastatic colon carcinoma cells. Int J Cancer 91: 67-75, 2001.
17. Honn KV, Tang DG, Crissman JD. Platelets and cancer metastasis. Cancer Metastasis Rev 11: 325-351, 1992.
18. Im JH, Fu W, Wang H, Bhatia SK, Hammer DA, Kowalska MA, Muschel RJ. Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation. Cancer Res 64: 8613-8619, 2004.
19. Iversen LH, Thorlacius-Ussing O. Systemic coagulation reactivation in recurrence of colorectal cancer. Thromb Haemost 89: 726-734, 2003.
20. Jadhav S, Bochner BS, Konstantopoulos K. Hydrodynamic shear regulates the kinetics and receptor specificity of polymorphonuclear leukocyte-colon carcinoma cell adhesive interactions. J Immunol 167: 5986-5993, 2001.
21. Jadhav S, Eggleton CD, Konstantopoulos K. Mathematical modeling of cell adhesion in shear flow pertinent to inflammation and cancer metastasis. Curr Pharm Des 13: 1511-1526, 2007.
22. Jadhav S, Konstantopoulos K. Fluid shear- and time-dependent modulation of molecular interactions between polymorphonuclear leukocytes and colon carcinomas. Am J Physiol Cell Physiol 283: C1133-C1143, 2002.
23. Karpatkin S, Pearlstein E, Ambrogio C, Coller BS. Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. J Clin Invest 81: 1012-1019, 1988.
24. Kim H, Yang XL, Rosada C, Hamilton SR, August JT. CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation. Arch Biochem Biophys 310: 504-507, 1994.
25. Kim HR, Wheeler MA, Wilson CM, Iida J, Eng D, Simpson MA, McCarthy JB, Bullard KM. Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44. Cancer Res 64: 4569-4576, 2004.
26. Kim YJ, Borsig L, Varki NM, Varki A. P-selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci USA 95: 9325-9330, 1998.
27. Konstantopoulos K, Kukreti S, McIntire LV. Biomechanics of cell interactions in shear fields. Adv Drug Deliv Rev 33: 141-164, 1998.
28. Labarriere N, Piau JP, Otry C, Denis M, Lustenberger P, Meflah K, Le Pendu J. H blood group antigen carried by CD44V modulates tumorigenicity of rat colon carcinoma cells. Cancer Res 54: 6275-6281, 1994.
29. Laubli H, Stevenson JL, Varki A, Varki NM, Borsig L. L-selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest. Cancer Res 66: 1536-1542, 2006.
30. Luzzatto G, Schafer AI. The prethrombotic state in cancer. Semin Oncol 17: 147-159, 1990.
31. Makogonenko E, Tsurupa G, Ingham K, Medved L. Interaction of fibrin(ogen) with fibronectin: further characterization and localization of the fibronectin-binding site. Biochemistry 41: 7907-7913, 2002.
32. Mannori G, Crottet P, Cecconi O, Hanasaki K, Aruffo A, Nelson RM, Varki A, Bevilacqua MP. Differential colon cancer cell adhesion to E-, P-, and L-selectin: role of mucin-type glycoproteins. Cancer Res 55: 4425-4431, 1995.
33. Mannori G, Santoro D, Carter L, Corless C, Nelson RM, Bevilacqua MP. Inhibition of colon carcinoma cell lung colony formation by a soluble form of E-selectin. Am J Pathol 151: 233-243, 1997.
34. McCarty OJ, Tien N, Bochner BS, Konstantopoulos K. Exogenous eosinophil activation converts PSGL-1-dependent binding to CD18-dependent stable adhesion to platelets in shear flow. Am J Physiol Cell Physiol 284: C1223-C1234, 2003.
35. McCarty OJT, Jadhav S, Burdick MM, Bell WR, Konstantopoulos K. Fluid shear regulates the kinetics and molecular mechanisms of activation-dependent platelet binding to colon carcinoma cells. Biophys J 83: 836-848, 2002.
36. McCarty OJT, Mousa SA, Bray PF, Konstantopoulos K. Immobilized platelets support human colon carcinoma cell tethering, rolling and firm adhesion under dynamic flow conditions. Blood 96: 1789-1797, 2000.
37. Mousa SA, Abulencia JP, McCarty OJ, Turner NA, Konstantopoulos K. Comparative efficacy between the glycoprotein IIb/IIIa antagonists roxifiban and orbofiban in inhibiting platelet responses in flow models of thrombosis. J Cardiovasc Pharmacol 39: 552-560, 2002.
38. Napier SL, Healy ZR, Schnaar RL, Konstantopoulos K. Selectin ligand expression regulates the initial vascular interactions of colon carcinoma cells: the roles of CD44V and alternative sialofucosylated selectin ligands. J Biol Chem 282: 3433-3441, 2007.
39. Nieswandt B, Hafner M, Echtenacher B, Mannel DN. Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 59: 1295-1300, 1999.
40. Palumbo JS, Kombrinck KW, Drew AF, Grimes TS, Kiser JH, Degen JL, Bugge TH. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood 96: 3302-3309, 2000.
41. Palumbo JS, Potter JM, Kaplan LS, Talmage K, Jackson DG, Degen JL. Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice. Cancer Res 62: 6966-6972, 2002.
42. Palumbo JS, Talmage KE, Massari JV, La Jeunesse CM, Flick MJ, Kombrinck KW, Jirouskova M, Degen JL. Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood 105: 178-185, 2005.
43. Pawar P, Shin PK, Mousa SA, Ross JM, Konstantopoulos K. Fluid shear regulates the kinetics and receptor specificity of Staphylococcus aureus binding to activated platelets. J Immunol 173: 1258-1265, 2004.
44. Pinedo HM, Verheul HM, D'Amato RJ, Folkman J. Involvement of platelets in tumour angiogenesis? Lancet 352: 1775-1777, 1998.
45. Ponta H, Sherman L, Herrlich PA. CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 4: 33-45, 2003.
46. Reeder JA, Gotley DC, Walsh MD, Fawcett J, Antalis TM. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment. Cancer Res 58: 3719-3726, 1998.
47. Smith MJ, Berg EL, Lawrence MB. A direct comparison of selectin-mediated transient, adhesive events using high temporal resolution. Biophys J 77: 3371-3383, 1999.
48. Springer TA. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 57: 827-872, 1995.
49. Svee K, White J, Vaillant P, Jessurun J, Roongta U, Krumwiede M, Johnson D, Henke C. Acute lung injury fibroblast migration and invasion of a fibrin matrix is mediated by CD44. J Clin Invest 98: 1713-1727, 1996.
50. Tandon P, Diamond SL. Hydrodynamic effects and receptor interactions of platelets and their aggregates in linear shear flow. Biophys J 73: 2819-2835, 1997.
51. Thomas L, Byers HR, Vink J, Stamenkovic I. CD44H regulates tumor cell migration on hyaluronate-coated substrate. J Cell Biol 118: 971-977, 1992.
52. Weisel JW. Fibrinogen and fibrin. Adv Protein Chem 70: 247-299, 2005.
53. Wielenga VJ, Heider KH, Offerhaus GJ, Adolf GR, van den Berg FM, Ponta H, Herrlich P, Pals ST. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 53: 4754-4756, 1993.
54. Wielenga VJ, Smits R, Korinek V, Smit L, Kielman M, Fodde R, Clevers H, Pals ST. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol 154: 515-523, 1999.
55. Wojtukiewicz MZ, Zacharski LR, Moritz TE, Hur K, Edwards RL, Rickles FR. Prognostic significance of blood coagulation tests in carcinoma of the lung and colon. Blood Coagul Fibrinolysis 3: 429-437, 1992.
56. Yakovlev S, Gorlatov S, Ingham K, Medved L. Interaction of fibrin (ogen) with heparin: further characterization and localization of the heparin-binding site. Biochemistry 42: 7709-7716, 2003.